deltatrials
Completed NCT01625663

Heart and Muscle Metabolism in Barth Syndrome

Heart and Skeletal Muscle Metabolism, Energetics and Function in Barth Syndrome

Sponsor: Duke University

Conditions Barth Syndrome
Updated 16 times since 2017 Last updated: May 29, 2020 Started: Jun 30, 2012 Primary completion: Mar 31, 2020 Completion: Mar 31, 2020

Listed as NCT01625663, this observational or N/A phase trial focuses on Barth Syndrome and remains completed. Sponsored by Duke University, it has been updated 16 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

16 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Dec 2021 — Jul 2024 [monthly]

    Completed

  5. Jan 2021 — Dec 2021 [monthly]

    Completed

Show 11 earlier versions
  1. Nov 2020 — Jan 2021 [monthly]

    Completed

  2. Jul 2020 — Nov 2020 [monthly]

    Completed

  3. Jun 2020 — Jul 2020 [monthly]

    Completed

    Status: RecruitingCompleted

  4. Aug 2019 — Jun 2020 [monthly]

    Recruiting

  5. Jun 2019 — Aug 2019 [monthly]

    Recruiting

  6. Jun 2018 — Jun 2019 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  9. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  10. Feb 2017 — Aug 2017 [monthly]

    Recruiting NA

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Duke University
  • University of Florida
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • St Louis, United States